Your browser doesn't support javascript.
loading
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.
Schwab, Lukas; Goroncy, Luise; Palaniyandi, Senthilnathan; Gautam, Sanjivan; Triantafyllopoulou, Antigoni; Mocsai, Attila; Reichardt, Wilfried; Karlsson, Fridrik J; Radhakrishnan, Sabarinath V; Hanke, Kathrin; Schmitt-Graeff, Annette; Freudenberg, Marina; von Loewenich, Friederike D; Wolf, Philipp; Leonhardt, Franziska; Baxan, Nicoleta; Pfeifer, Dietmar; Schmah, Oliver; Schönle, Anne; Martin, Stefan F; Mertelsmann, Roland; Duyster, Justus; Finke, Jürgen; Prinz, Marco; Henneke, Philipp; Häcker, Hans; Hildebrandt, Gerhard C; Häcker, Georg; Zeiser, Robert.
Affiliation
  • Schwab L; 1] Department of Hematology and Oncology, University Medical Center, Freiburg, Germany. [2].
  • Goroncy L; 1] Department of Hematology and Oncology, University Medical Center, Freiburg, Germany. [2] Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany. [3].
  • Palaniyandi S; 1] Division of Hematology and Oncology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA. [2] Division of Bone Marrow Transplantation, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA. [3].
  • Gautam S; 1] Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany. [2] Department of Medical Microbiology and Hygiene, University Medical Center, Freiburg, Germany. [3] Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-University Freiburg, Germany.
  • Triantafyllopoulou A; Center of Chronic Immunodeficiency, Albert-Ludwigs-University Freiburg, Germany.
  • Mocsai A; Department of Physiology, Semmelweis University School of Medicine, Budapest, Hungary.
  • Reichardt W; Department of Radiology Medical Physics, University Medical Center, Freiburg, Germany.
  • Karlsson FJ; Division of Hematology and Oncology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
  • Radhakrishnan SV; 1] Division of Hematology and Oncology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA. [2] Division of Bone Marrow Transplantation, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA.
  • Hanke K; 1] Department of Hematology and Oncology, University Medical Center, Freiburg, Germany. [2] Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany.
  • Schmitt-Graeff A; Department of Pathology, University Medical Center, Albert-Ludwigs-University, Freiburg, Germany.
  • Freudenberg M; 1] Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. [2] Centre for Biological Signaling Studies BIOSS, Albert-Ludwigs-University Freiburg, Germany.
  • von Loewenich FD; Department of Medical Microbiology and Hygiene, University Medical Center, Freiburg, Germany.
  • Wolf P; Department of Urology, University Medical Center, Freiburg, Germany.
  • Leonhardt F; 1] Department of Hematology and Oncology, University Medical Center, Freiburg, Germany. [2] Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany.
  • Baxan N; Department of Radiology Medical Physics, University Medical Center, Freiburg, Germany.
  • Pfeifer D; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
  • Schmah O; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
  • Schönle A; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
  • Martin SF; Allergy Research Group, Department of Dermatology, University Medical Center, University Freiburg, Germany.
  • Mertelsmann R; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
  • Duyster J; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
  • Finke J; Department of Hematology and Oncology, University Medical Center, Freiburg, Germany.
  • Prinz M; 1] Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-University Freiburg, Germany. [2] Department of Neuropathology, University Medical Center, Freiburg, Germany.
  • Henneke P; 1] Center of Chronic Immunodeficiency, Albert-Ludwigs-University Freiburg, Germany. [2] Center for Pediatrics and Adolescent Medicine, University Medical Center, Freiburg, Germany.
  • Häcker H; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Hildebrandt GC; 1] Division of Hematology and Oncology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA. [2] Division of Bone Marrow Transplantation, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, USA. [3].
  • Häcker G; 1] Department of Medical Microbiology and Hygiene, University Medical Center, Freiburg, Germany. [2] Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-University Freiburg, Germany. [3].
  • Zeiser R; 1] Department of Hematology and Oncology, University Medical Center, Freiburg, Germany. [2] Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-University Freiburg, Germany. [3] Centre for Biological Signaling Studies BIOSS, Albert-Ludwigs-University Freiburg, Germany. [4].
Nat Med ; 20(6): 648-54, 2014 Jun.
Article in En | MEDLINE | ID: mdl-24836575
ABSTRACT
Acute graft-versus-host disease (GVHD) considerably limits wider usage of allogeneic hematopoietic cell transplantation (allo-HCT). Antigen-presenting cells and T cells are populations customarily associated with GVHD pathogenesis. Of note, neutrophils are the largest human white blood cell population. The cells cleave chemokines and produce reactive oxygen species, thereby promoting T cell activation. Therefore, during an allogeneic immune response, neutrophils could amplify tissue damage caused by conditioning regimens. We analyzed neutrophil infiltration of the mouse ileum after allo-HCT by in vivo myeloperoxidase imaging and found that infiltration levels were dependent on the local microbial flora and were not detectable under germ-free conditions. Physical or genetic depletion of neutrophils reduced GVHD-related mortality. The contribution of neutrophils to GVHD severity required reactive oxygen species (ROS) because selective Cybb (encoding cytochrome b-245, beta polypeptide, also known as NOX2) deficiency in neutrophils impairing ROS production led to lower levels of tissue damage, GVHD-related mortality and effector phenotype T cells. Enhanced survival of Bcl-xL transgenic neutrophils increased GVHD severity. In contrast, when we transferred neutrophils lacking Toll-like receptor-2 (TLR2), TLR3, TLR4, TLR7 and TLR9, which are normally less strongly activated by translocating bacteria, into wild-type C57BL/6 mice, GVHD severity was reduced. In humans, severity of intestinal GVHD strongly correlated with levels of neutrophils present in GVHD lesions. This study describes a new potential role for neutrophils in the pathogenesis of GVHD in both mice and humans.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Microbiota / Graft vs Host Disease / Ileum / Neutrophils Limits: Animals Language: En Year: 2014 Type: Article

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Microbiota / Graft vs Host Disease / Ileum / Neutrophils Limits: Animals Language: En Year: 2014 Type: Article